|
|
|
Insider
Information: |
Newhall Charles W III |
Relationship: |
Director |
City: |
Baltimore |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
17 |
|
Direct
Shares |
1,746,114 |
|
Indirect Shares
|
133,127,843 |
|
|
Direct
Value |
$3,805,617 |
|
|
Indirect Value
|
$184,247,397 |
|
|
Total
Shares |
134,873,957 |
|
|
Total
Value |
$188,053,015 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-44.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Welltek Incorporated |
WTKND |
Former 10% Owner |
2004-05-06 |
1,149 |
2004-09-28 |
14,470 |
Premium* |
|
Aradigm Corp |
ARDM |
10% Owner |
2003-12-11 |
51 |
2004-02-20 |
0 |
Premium* |
|
FoxHollow Technologies |
FOXH |
Former 10% Owner |
2004-11-02 |
0 |
2004-11-02 |
1,804,462 |
Premium* |
|
DZS Inc |
DZSI |
10% Owner |
2005-02-10 |
0 |
2008-03-10 |
12,051,646 |
Premium* |
|
Occam Networks Inc |
OCNW |
Former 10% Owner |
2006-11-07 |
1,623,555 |
2006-04-07 |
0 |
Premium* |
|
Gyre Therapeutics |
GYRE |
10% Owner |
2006-04-12 |
0 |
2008-01-17 |
4,565,512 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2009-01-30 |
2,083,426 |
Premium* |
|
Vonage Holdings Corp |
VG |
10% Owner |
2006-05-30 |
0 |
2011-03-11 |
22,793 |
Premium* |
|
Innerworkings Inc |
INWK |
10% Owner |
2007-11-16 |
0 |
2012-03-28 |
15,000 |
Premium* |
|
Pharmos Corp |
PARS |
Director, 10% Owner |
|
0 |
2009-05-08 |
14,435,105 |
Premium* |
|
Amicus Therapeutics Inc |
FOLD |
10% Owner |
2007-06-05 |
0 |
2012-03-07 |
4,584,311 |
Premium* |
|
Echo Global Logistics Inc |
ECHO |
10% Owner |
2012-02-28 |
95 |
2012-02-28 |
0 |
Premium* |
|
Financial Engines, Inc. |
FNGN |
10% Owner |
|
0 |
2010-08-30 |
3,481,941 |
Premium* |
|
Groupon, Inc. |
GRPN |
10% Owner |
|
0 |
2011-11-03 |
87,184,956 |
Premium* |
|
Hyperion Therapeutics Inc |
HPTX |
10% Owner |
|
0 |
2012-07-31 |
2,884,221 |
Premium* |
|
Supernus Pharmaceuticals Inc |
SUPN |
Director |
2024-02-23 |
120,975 |
2015-06-15 |
0 |
Premium* |
|
Vitae Pharmaceuticals, Inc |
VTAE |
Director |
2015-07-01 |
289 |
2015-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
182 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2015-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
26,012 |
26,012 |
0 |
- |
|
FNGN |
Financial Engines, Inc. |
10% Owner |
|
2010-03-19 |
4 |
A |
$0.00 |
$0 |
I/I |
3,203,170 |
49,093 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2015-11-11 |
4 |
A |
$0.00 |
$0 |
D/D |
33,159 |
59,171 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2015-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
33,127 |
92,298 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2020-02-21 |
4 |
A |
$23.99 |
$125,012 |
D/D |
5,211 |
97,509 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2022-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
4,222 |
101,731 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2022-12-28 |
4 |
OE |
$7.90 |
$68,904 |
D/D |
8,722 |
110,453 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2023-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
3,882 |
112,132 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2023-11-16 |
4 |
S |
$28.01 |
$70,025 |
D/D |
(2,500) |
117,089 |
0 |
% |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2023-11-16 |
4 |
OE |
$9.24 |
$68,903 |
D/D |
7,457 |
119,589 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
Director |
|
2024-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,886 |
120,975 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
10% Owner |
|
2006-04-12 |
4 |
B |
$9.00 |
$3,150,000 |
I/I |
350,000 |
350,000 |
1.5 |
- |
|
FOLD |
Amicus Therapeutics Inc |
10% Owner |
|
2007-06-05 |
4 |
A |
$0.00 |
$0 |
I/I |
4,472,224 |
821,736 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
10% Owner |
|
2007-07-25 |
4 |
A |
$11.49 |
$338,452 |
I/I |
29,447 |
851,183 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
|
2009-01-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,103,283 |
1,103,283 |
0 |
- |
|
FNGN |
Financial Engines, Inc. |
10% Owner |
|
2010-03-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,538,180 |
|
- |
|
HPTX |
Hyperion Therapeutics Inc |
10% Owner |
|
2012-07-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(51,119) |
1,588,099 |
0 |
- |
|
OCNW |
Occam Networks Inc |
Former 10% Owner |
|
2006-11-07 |
4 |
S |
$14.00 |
$3,416,000 |
D/D |
(244,000) |
1,623,555 |
0 |
- |
|
HPTX |
Hyperion Therapeutics Inc |
10% Owner |
|
2012-07-31 |
4 |
OE |
$0.00 |
$0 |
I/I |
125,291 |
1,639,218 |
0 |
- |
|
FOXH |
FoxHollow Technologies |
Former 10% Owner |
|
2004-11-02 |
4 |
A |
$0.00 |
$0 |
I/I |
1,804,462 |
1,804,462 |
|
- |
|
OCNW |
Occam Networks Inc |
Former 10% Owner |
|
2006-11-07 |
4 |
A |
$0.00 |
$0 |
D/D |
727,272 |
1,867,555 |
0 |
- |
|
PARS |
Pharmos Corp |
Director |
|
2006-10-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,880,824 |
|
- |
|
PARS |
Pharmos Corp |
Director |
|
2008-07-17 |
4 |
A |
$0.36 |
$53,201 |
I/I |
148,605 |
2,029,429 |
0 |
- |
|
PARS |
Pharmos Corp |
Director |
|
2008-08-05 |
4/A |
A |
$0.36 |
$53,201 |
I/I |
148,605 |
2,029,429 |
0 |
- |
|
PARS |
Pharmos Corp |
Director |
|
2009-01-15 |
4 |
A |
$0.34 |
$50,000 |
I/I |
147,059 |
2,176,488 |
0 |
- |
|
182 Records found
|
|
Page 2 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|